Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec 3;12(1):102.
doi: 10.1186/s13041-019-0523-7.

Silencing of microRNA-146a alleviates the neural damage in temporal lobe epilepsy by down-regulating Notch-1

Affiliations

Silencing of microRNA-146a alleviates the neural damage in temporal lobe epilepsy by down-regulating Notch-1

Hui Huang et al. Mol Brain. .

Abstract

This study aimed to evaluate the specific regulatory roles of microRNA-146a (miRNA-146a) in temporal lobe epilepsy (TLE) and explore the related regulatory mechanisms. A rat model of TLE was established by intraperitoneal injection of lithium chloride-pilocarpine. These model rats were injected intracerebroventricularly with an miRNA-146a inhibitor and Notch-1 siRNA. Then, neuronal damage and cell apoptosis in the cornu ammonis (CA) 1 and 3 regions of the hippocampus were assessed. SOD and MDA levels in the hippocampus were detected by chromatometry, and IL-1β, IL-6, and IL-18 levels were detected by ELISA. Then, we evaluated the expression levels of caspase-9, GFAP, Notch-1, and Hes-1 in the hippocampus. The interaction between Notch-1 and miRNA-146a was assessed by a dual luciferase reporter gene assay. A rat model of TLE was successfully established, which exhibited significantly increased miRNA-146a expression in the hippocampus. Silencing of miRNA-146a significantly alleviated the neuronal damage and cell apoptosis in the CA1 and CA3 regions of the hippocampus in TLE rats and decreased MDA, IL-1β, IL-6, and IL-18 levels and increased SOD levels in the hippocampus of TLE rats. In addition, silencing of miRNA-146a significantly decreased the expression levels of caspase-9, GFAP, Notch-1, and Hes-1 in the hippocampus of TLE rats. Notch-1 was identified as a target of miRNA-146a and silencing of Notch-1 aggravated the neuronal damage in the CA1 and CA3 regions. Silencing of miRNA-146a alleviated the neuronal damage in the hippocampus of TLE rats by down-regulating Notch-1.

Keywords: Caspase-9; Neuronal damage; Notch-1; Temporal lobe epilepsy; microRNA-146a.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
The electroencephalograms (EEGs) of rats were measured after 24 h post-epilepsy occurrence. Model, temporal lobe epilepsy (TLE) rats; Control, normal rats. a EEGs; b) the number of spike-and-wave discharges (SWDs). *, P < 0.05 vs. Control group
Fig. 2
Fig. 2
The expression of microRNA-146a (miRNA-146a) in hippocampus of rats detected by quantitative real-time PCR (qRT-PCR) (N = 8) at 3 days after the injection. Model, temporal lobe epilepsy (TLE) rats; Control, normal rats. *, P < 0.05 vs. Control group; #, P < 0.05 vs. Model group
Fig. 3
Fig. 3
Pathological morphology of cornu ammonis (CA)1 and CA3 regions in hippocampus of rats were detected by hematoxylin-eosin (HE) staining (× 400) (N = 8) at 3 days after the injection. Model, temporal lobe epilepsy (TLE) rats; Control, normal rats; microRNA-146a (miRNA-146a) siRNA, TLE rats transfected with miRNA-146a siRNA; miRNA-146a negative control (miRNA-146a NC), TLE rats transfected with miRNA-146a NC. a CA1 region; b) CA3 region. Arrows represented the accumulation area of neurons
Fig. 4
Fig. 4
The levels of SOD and MDA in hippocampus of rats were detected by chromatometry (N = 8) at 3 days after the injection. Model, temporal lobe epilepsy (TLE) rats; Control, normal rats; microRNA-146a (miRNA-146a) siRNA, TLE rats transfected with miRNA-146a siRNA; miRNA-146a negative control (miRNA-146a NC), TLE rats transfected with miRNA-146a NC. a SOD level; b) MDA level. *, P < 0.05 vs. Control group; #, P < 0.05 vs. Model group
Fig. 5
Fig. 5
The levels of IL-1β, IL-6, and IL-18 in hippocampus of rats were detected by enzyme linked immunosorbent assay (ELISA) (N = 8) at 3 days after the injection. Model, temporal lobe epilepsy (TLE) rats; Control, normal rats; microRNA-146a (miRNA-146a) siRNA, TLE rats transfected with miRNA-146a siRNA; miRNA-146a negative control (miRNA-146a NC), TLE rats transfected with miRNA-146a NC. a IL-1β; b) IL-6; c) IL-18. *, P < 0.05 vs. Control group; #, P < 0.05 vs. Model group
Fig. 6
Fig. 6
Cell apoptosis in CA1 and CA3 regions of hippocampus in rats detected by TUNEL (N = 5). Model, temporal lobe epilepsy (TLE) rats; Control, normal rats; microRNA-146a (miRNA-146a), TLE rats transfected with miRNA-146a siRNA; miRNA-146a negative control (miRNA-146a NC), TLE rats transfected with miRNA-146a NC. a microscopic observation of apoptotic cells in CA1 region; b) the number of apoptotic cells in stratum pyramidale of CA1 region; c) microscopic observation of apoptotic cells in CA3 region; d) the number of apoptotic cells in stratum pyramidale of CA3 region. *, P < 0.05 vs. Control group; #, P < 0.05 vs. Model group
Fig. 7
Fig. 7
The expression of caspase-9 and GFAP in hippocampus was detected by immunohistochemistry (ICH) (× 400) (N = 8) at 3 days after the injection. Model, temporal lobe epilepsy (TLE) rats; Control, normal rats; microRNA-146a (miRNA-146a), TLE rats transfected with miRNA-146a siRNA; miRNA-146a negative control (miRNA-146a NC), TLE rats transfected with miRNA-146a NC. a microscopic observation of caspase-9-positive cells; b) the expression level of caspase-9; c) microscopic observation of GFAP-positive cells; d) the expression level of GFAP. *, P < 0.05 vs. Control group; #, P < 0.05 vs. Model group
Fig. 8
Fig. 8
The expression of Notch-1, Hes-1 and caspase-9 in hippocampus detected by quantitative real-time PCR (qRT-PCR) and/or Western blot (N = 8) was performed at 3 days after the injection. Model, temporal lobe epilepsy (TLE) rats; Control, normal rats; microRNA-146a (miRNA-146a), TLE rats transfected with miRNA-146a siRNA; miRNA-146a negative control (miRNA-146a NC), TLE rats transfected with miRNA-146a NC. a the expression of Notch-1 detected by qRT-PCR (mRNA level); b) the expression of Notch-1, Hes-1 and caspase-9 detected by Western blot (protein level). *, P < 0.05 vs. Control group; **, P < 0.01 vs. Control group; #, P < 0.05 vs. Model group
Fig. 9
Fig. 9
The interaction between Notch-1 and microRNA-146a (miRNA-146a). a a binding site of miRNA-146a at 3′-UTR of Notch-1 predicted by Target Scan; b) the relative fluorescence unit of co-transfected cells detected by dual luciferase reporter gene (DLR) assay. *, P < 0.05 vs. Notch-1-WT + miRNA-146a inhibitor. c Spearman’s rank correlation analysis was used to detect the correlation between Notch1 and miRNA-146a expression. d The expression of miRNA-146a transfected with miRNA-146a mimics or miRNA-146a mimics NC in the hippocampus of rats was detected by qRT-PCR. e Western blot analysis was used to detect the expression of Notch1 protein after transfected with miRNA-146a mimics or miRNA-146a mimics NC in the hippocampus of rats. *, P < 0.05 vs. miRNA-146a mimics NC
Fig. 10
Fig. 10
Silence Notch1 aggravated the severity of epileptic brain damage. a Rats (N = 8 in each group) were injected intracerebroventricularly with siRNA negative control (siRNA NC) or siRNA targeting Notch1 (siRNA Notch1) for three days and relative Notch1 expression was assessed by qRT-PCR to detect the siRNA efficiency against Notch1. After transfection of 3 days, the levels of SOD (b), MDA (c), IL-1β (d), IL-6 (e) and IL-18 (f) were detected. *P < 0.05 vs. siNC group. Photomicrographs of apoptotic cells in CA1 region (g) and (h) CA3 region (arrows indicate the positive cells, bar = 100 μm, magnification × 400)

References

    1. Raoof R, Jimenez-Mateos EM, Bauer S, Tackenberg B, Rosenow F, Lang J, et al. Cerebrospinal fluid microRNAs are potential biomarkers of temporal lobe epilepsy and status epilepticus. Sci Rep. 2017:7. - PMC - PubMed
    1. Spencer SS. Neural networks in human epilepsy: evidence of and implications for treatment. Epilepsia. 2010;43:219–227. doi: 10.1046/j.1528-1157.2002.26901.x. - DOI - PubMed
    1. Thom M, Eriksson S, Martinian L, Caboclo LO, Mcevoy AW, Duncan JS, et al. Temporal lobe sclerosis associated with hippocampal sclerosis in temporal lobe epilepsy: Neuropathological features. J Neuropathol Exp Neurol. 2009;68:928–938. doi: 10.1097/NEN.0b013e3181b05d67. - DOI - PMC - PubMed
    1. Coyle A, Riley J, Wu C, Sharan A. From resection to ablation: a review of resective surgical options for temporal lobe epilepsy and rationale for an ablation-based approach. Neurol India. 2017;65:S71. - PubMed
    1. Bonilha L, Keller SS. Quantitative MRI in refractory temporal lobe epilepsy: relationship with surgical outcomes. Quant Imaging Med Surg. 2015;5:204. - PMC - PubMed

MeSH terms

LinkOut - more resources